Reumatología

2022

1. A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome

   International Journal of Molecular Sciences, Vol. 23, Núm. 23

2. A new immunometabolic perspective of intervertebral disc degeneration

   Nature Reviews Rheumatology, Vol. 18, Núm. 1, pp. 47-60

3. Action Mechanisms of Small Extracellular Vesicles in Inflammaging

   Life, Vol. 12, Núm. 4

4. Adipokines as targets in musculoskeletal immune and inflammatory diseases

   Drug Discovery Today, Vol. 27, Núm. 11

5. After JAK inhibitor failure: To cycle or to switch, that is the question - Data from the JAK-pot collaboration of registries

   Annals of the Rheumatic Diseases, Vol. 82, Núm. 2, pp. 175-181

6. Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout

   British Journal of Pharmacology, Vol. 179, Núm. 2, pp. 270-286

7. Analgesic and antiinflammatory effects of Nigella orientalis L. seeds fixed oil: Pharmacological potentials and molecular mechanisms

   Phytotherapy Research, Vol. 36, Núm. 3, pp. 1372-1385

8. Analysis of changes in the proteomic profile of porcine corpus luteum during different stages of the oestrous cycle: Effects of PPAR gamma ligands

   Reproduction, Fertility and Development, Vol. 34, Núm. 11, pp. 776-788

9. Analysis of the implementation of an innovative IT solution to improve waiting times, communication with primary care and efficiency in Rheumatology

   BMC Health Services Research, Vol. 22, Núm. 1

10. Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis

    Diagnostics, Vol. 12, Núm. 2

11. Antifibrotic effect of brown algae-derived fucoidans on osteoarthritic fibroblast-like synoviocytes

    Carbohydrate Polymers, Vol. 282

12. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52

13. Association of the serological status of rheumatoid arthritis patients with two circulating protein biomarkers: A useful tool for precision medicine strategies

    Frontiers in Medicine, Vol. 9

14. Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

15. Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review

    Rheumatology (Oxford, England), Vol. 61, Núm. 11, pp. 4427-4436

16. Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 74, Núm. 6, pp. 972-983

17. Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry

    ACR Open Rheumatology, Vol. 4, Núm. 11, pp. 948-953

18. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

    Annals of the rheumatic diseases, Vol. 81, Núm. 7, pp. 970-978

19. Characteristics associated with the perception of high-impact disease (PsAID ≥4) in patients with recent-onset psoriatic arthritis. Machine learning-based model

    Seminars in Arthritis and Rheumatism, Vol. 57

20. Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14